Q&A With Oblon Spivak's Dan Pereira

Law360, New York (June 22, 2012, 2:13 PM EDT) -- Daniel J. Pereira, Ph.D., a chemical biotech patent attorney, is a partner in the Alexandria, Va., office of Oblon Spivak McClelland Maier & Neustadt LLP. His practice focuses on client counseling, portfolio management, patent prosecution, litigation and interferences, with particular emphasis in the medical, biotechnology, and pharmaceutical fields. Pereira has also provided extensive prelitigation and litigation avoidance counseling to clients.

Prior to joining Oblon Spivak, Pereira worked as a postdoctoral research scientist at the Mount Sinai School of Medicine conducting research in the fields of neurodegeneration,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.